Bert Hoyt Joins dBio as Board Advisor
Former Nike VP and GM Bert Hoyt has joined Decentralized Biotechnology Intelligence Holding Group Inc. as a Board Advisor, announced in a press release. Hoyt, with over 32 years of experience in the sports industry, will bring strategic insights to dBio's mission of revolutionizing personalized healthcare and fitness technologies.
dBio is known for its advanced wearable AIoT solutions, including the gMOTCloud, an AI-powered kinesiology wearable, and StethoCloud, a wearable stethoscope for continuous health monitoring. These technologies aim to optimize athletic performance and provide real-time health insights.
Bert Hoyt's extensive background includes leadership roles at Nike, where he significantly contributed to the company's growth in Western Europe and EMEA. His expertise is expected to support dBio's expansion and innovation in the sports and health tech sectors.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read more